PEMGX
Price
$43.67
Change
+$0.14 (+0.32%)
Updated
Jun 20 closing price
Net Assets
30.52B
WSMNX
Price
$22.87
Change
-$0.05 (-0.22%)
Updated
Jun 20 closing price
Net Assets
1.41B
Interact to see
Advertisement

PEMGX vs WSMNX

Header iconPEMGX vs WSMNX Comparison
Open Charts PEMGX vs WSMNXBanner chart's image
Principal MidCap A
Price$43.67
Change+$0.14 (+0.32%)
VolumeN/A
Net Assets30.52B
William Blair Small-Mid Cap Growth N
Price$22.87
Change-$0.05 (-0.22%)
VolumeN/A
Net Assets1.41B
PEMGX vs WSMNX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
PEMGX vs. WSMNX commentary
Jun 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PEMGX is a Buy and WSMNX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PEMGX has more cash in the bank: 30.5B vs. WSMNX (1.41B). PEMGX (0.00) and WSMNX (0.00) have matching dividends . PEMGX was incepted earlier than WSMNX: PEMGX (20 years) vs WSMNX (21 years). WSMNX (1.36) is less costly to investors than PEMGX (0.91). WSMNX is a more actively managed with annual turnover of: 63.00 vs. PEMGX (10.50). PEMGX has a lower initial minimum investment than WSMNX: PEMGX (1000) vs WSMNX (2500). PEMGX annual gain was more profitable for investors over the last year : 9.59 vs. WSMNX (-12.72). PEMGX return over 5 years is better than : 51.04 vs. WSMNX (-10.57).
PEMGXWSMNXPEMGX / WSMNX
Total Expense Ratio0.911.2473%
Annual Report Gross Expense Ratio0.911.3667%
Fund Existence20 years21 years-
Gain YTD2.135-9.443-23%
Front Load6%N/A-
Min. Initial Investment1000250040%
Min. Initial Investment IRAN/AN/A-
Net Assets30.5B1.41B2,168%
Annual Yield % from dividends0.000.00-
Returns for 1 year9.59-12.72-75%
Returns for 3 years50.620.4810,497%
Returns for 5 years51.04-10.57-483%
Returns for 10 years86.9510.40836%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CZR28.140.39
+1.41%
Caesars Entertainment
ATGE125.080.58
+0.47%
Adtalem Global Education
ESPR1.07-0.03
-2.73%
Esperion Therapeutics
LIXT0.78-0.05
-6.33%
Lixte Biotechnology Holdings
MYO2.42-0.29
-10.70%
Myomo